Welcome Address

...We are pleased to announce that the 11th Brain Tumor Meeting will take place at the Max Delbrück Center for Molecular Medicine (MDC) in Berlin (Germany) in 2022.  The Brain Tumor meeting is an open scientific forum organized to foster the development of multi-center, international and inter-disciplinary collaborations that will lead to a better understanding of the etiology, biology, outcomes, and prevention of brain tumors. The two-day conference on brain tumor biology and genetics provides an excellent opportunity for clinicians, neuroscientists, neuro-oncologists, Pls, postdocs, PhD students and research technicians to meet, present and discuss their work, build informal networks and set up new collaborations. More than 300 participants and almost 200 poster presentations in 2019 documented the increasing interest in the field. Internationally renowned speakers agreed to present their newest data on these topics. Furthermore, abstracts for oral and poster presentations are invited and the best presentations will be awarded a prize.
We expect exciting scientific exchange and invite you to join this meeting
.

The Scientific Committee

 

      

Scientific Committee:
Charlotte Flüh, UKSH, Kiel
Gaetano Gargiulo, MDC, Berlin-Buch
Christoph Harms, Charité Campus Mitte, Berlin
Helmut Kettenmann (Chair), MDC, Berlin-Buch
Michael Synowitz (Co-Chair), UKSH, Kiel
 
This meeting is an activity of
Max Delbrück Center for Molecular Medicine (MDC)
Charité - University Medicine Berlin
Universitätsklinikum Kiel
 
Conference Management:
Meino Alexandra Gibson
Verein zur Förderung der Neurowissenschaften am MDC e.V.
Max Delbrück Center for Molecular Medicine (MDC)
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Phone: +49 30 9406 3336
 

    
 

Travel grants available
The financial support consists of a maximum of 500 € for travel and accommdation.
 
Best Abstract Competition
Three prizes will be awarded for the best three abstracts presented at the Brain Tumor 2022 meeting. The winners are determined by scoring by program committee members and voting by the meeting participants.
 
 
 
 
 
 
 
 
 
 
 

Our partners

Commercial partners:
 
 
     
Partner Organisations:

European Association of NeuroOncology

British Neuro-Oncology Society